QuidelOrtho Corporation QDEL is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid preliminary revenue for fourth-quarter 2024, is ...

Trusted Healthcare IT advisors recognized for driving innovation, efficiency, and measurable success in the evolving digital landscape. NEW YORK CITY, NEW YORK / ACCESS Newswire / January 30, 2025 / ...

Learn more about whether Arch Capital Group Ltd. or Marsh & McLennan Companies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

One sector seeing a surge in interest is compression therapy, a market projected to grow from $4.18 billion in 2024 to $6.72 billion by 2033. Traditionally dominated by compression stockings and bulky ...

Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

Series B Preferred Stock shareholders will not be required to pay cash or other consideration for the shares of Common Stock to be distributed to them or to surrender or exchange their shares of ...